XDNA
Strategic Trust Kelly CRISPR & Gene Editing Technology ETF
XDNA
XDNA
Delisted
XDNA was delisted on the 30th of November, 2023.
2 hedge funds and large institutions have $95.8K invested in Strategic Trust Kelly CRISPR & Gene Editing Technology ETF in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$92.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.11K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $92.6K | +$92.6K | +12,486 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $3.11K | +$3.11K | +419 | New |
|